share_log

Truist Securities Maintains Buy on Amneal Pharmaceuticals, Raises Price Target to $7

Truist Securities Maintains Buy on Amneal Pharmaceuticals, Raises Price Target to $7

Truist Securities维持对Amneal Pharmicals的买入,将目标股价
Benzinga ·  2023/11/08 09:51

Truist Securities analyst Gregory Fraser maintains Amneal Pharmaceuticals (NYSE:AMRX) with a Buy and raises the price target from $6 to $7.

Truist Securities分析师格雷戈里·弗雷泽维持Amneal Pharmicals(纽约证券交易所代码:AMRX)的买入,并将目标股价从6美元上调至7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发